Rossari Biotech (India) Performance
| ROSSARI Stock | 793.45 8.50 1.08% |
The company holds a Beta of 0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, Rossari Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Rossari Biotech is expected to be smaller as well. At this point, Rossari Biotech has a negative expected return of -0.2%. Please make sure to check Rossari Biotech's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Rossari Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Forward Dividend Yield 0.0006 | Payout Ratio 0.02 | Forward Dividend Rate 0.5 | Ex Dividend Date 2024-08-16 |
1 | Rossari Biotech Confident Of 14 percent Revenue Growth In Fiscal 2025 - NDTV Profit | 10/23/2024 |
2 | Rossari Biotechs Stock Sees Positive Movement, Outperforms Sector and Market - MarketsMojo | 12/10/2024 |
| Begin Period Cash Flow | 692 M |
Rossari |
Rossari Biotech Relative Risk vs. Return Landscape
If you would invest 90,795 in Rossari Biotech Limited on September 28, 2024 and sell it today you would lose (11,450) from holding Rossari Biotech Limited or give up 12.61% of portfolio value over 90 days. Rossari Biotech Limited is generating negative expected returns and assumes 2.0823% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Rossari, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Rossari Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rossari Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Rossari Biotech Limited, and traders can use it to determine the average amount a Rossari Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0958
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ROSSARI |
Estimated Market Risk
| 2.08 actual daily | 18 82% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rossari Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rossari Biotech by adding Rossari Biotech to a well-diversified portfolio.
Rossari Biotech Fundamentals Growth
Rossari Stock prices reflect investors' perceptions of the future prospects and financial health of Rossari Biotech, and Rossari Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rossari Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0735 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 44.68 B | ||||
| Shares Outstanding | 55.36 M | ||||
| Price To Book | 3.93 X | ||||
| Price To Sales | 2.29 X | ||||
| Revenue | 18.31 B | ||||
| Gross Profit | 3.74 B | ||||
| EBITDA | 2.57 B | ||||
| Net Income | 1.31 B | ||||
| Total Debt | 1.19 B | ||||
| Book Value Per Share | 202.14 X | ||||
| Cash Flow From Operations | 432.55 M | ||||
| Earnings Per Share | 25.07 X | ||||
| Total Asset | 15.72 B | ||||
| Retained Earnings | 5.65 B | ||||
About Rossari Biotech Performance
By evaluating Rossari Biotech's fundamental ratios, stakeholders can gain valuable insights into Rossari Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Rossari Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Rossari Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Rossari Biotech is entity of India. It is traded as Stock on NSE exchange.Things to note about Rossari Biotech performance evaluation
Checking the ongoing alerts about Rossari Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rossari Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rossari Biotech generated a negative expected return over the last 90 days | |
| About 68.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Rossari Biotechs Stock Sees Positive Movement, Outperforms Sector and Market - MarketsMojo |
- Analyzing Rossari Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rossari Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Rossari Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rossari Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rossari Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rossari Biotech's stock. These opinions can provide insight into Rossari Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Rossari Stock analysis
When running Rossari Biotech's price analysis, check to measure Rossari Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rossari Biotech is operating at the current time. Most of Rossari Biotech's value examination focuses on studying past and present price action to predict the probability of Rossari Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rossari Biotech's price. Additionally, you may evaluate how the addition of Rossari Biotech to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |